JP2011500797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500797A5 JP2011500797A5 JP2010530951A JP2010530951A JP2011500797A5 JP 2011500797 A5 JP2011500797 A5 JP 2011500797A5 JP 2010530951 A JP2010530951 A JP 2010530951A JP 2010530951 A JP2010530951 A JP 2010530951A JP 2011500797 A5 JP2011500797 A5 JP 2011500797A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- disintegrant
- granules
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 49
- 238000000034 method Methods 0.000 claims 25
- 239000008187 granular material Substances 0.000 claims 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 18
- 239000007884 disintegrant Substances 0.000 claims 18
- 239000006186 oral dosage form Substances 0.000 claims 15
- BMPDWHIDQYTSHX-UHFFFAOYSA-N licarbazepine Chemical compound C1C(O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 BMPDWHIDQYTSHX-UHFFFAOYSA-N 0.000 claims 14
- 239000000203 mixture Substances 0.000 claims 14
- 239000011230 binding agent Substances 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 6
- 238000005469 granulation Methods 0.000 claims 6
- 230000003179 granulation Effects 0.000 claims 6
- 239000007788 liquid Substances 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 4
- 235000003599 food sweetener Nutrition 0.000 claims 4
- 239000003765 sweetening agent Substances 0.000 claims 4
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 3
- 229960001681 croscarmellose sodium Drugs 0.000 claims 3
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 3
- QIALRBLEEWJACW-INIZCTEOSA-N eslicarbazepine acetate Chemical group CC(=O)O[C@H]1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C12 QIALRBLEEWJACW-INIZCTEOSA-N 0.000 claims 3
- 229960003233 eslicarbazepine acetate Drugs 0.000 claims 3
- 239000000796 flavoring agent Substances 0.000 claims 3
- 235000013355 food flavoring agent Nutrition 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 3
- 229940069328 povidone Drugs 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000000945 filler Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 229920002261 Corn starch Polymers 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 claims 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- 230000006835 compression Effects 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 229960004667 ethyl cellulose Drugs 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- 229960003943 hypromellose Drugs 0.000 claims 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 229960002900 methylcellulose Drugs 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000008109 sodium starch glycolate Substances 0.000 claims 1
- 229940079832 sodium starch glycolate Drugs 0.000 claims 1
- 229920003109 sodium starch glycolate Polymers 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98279007P | 2007-10-26 | 2007-10-26 | |
| PCT/PT2008/000043 WO2009054743A1 (en) | 2007-10-26 | 2008-10-24 | Oral dosage forms comprising licarbazξpine acetate |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014141894A Division JP6043758B2 (ja) | 2007-10-26 | 2014-07-10 | 酢酸リカルバゼピンを含む経口剤形 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011500797A JP2011500797A (ja) | 2011-01-06 |
| JP2011500797A5 true JP2011500797A5 (enExample) | 2011-12-08 |
Family
ID=40254311
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010530951A Pending JP2011500797A (ja) | 2007-10-26 | 2008-10-24 | 酢酸リカルバゼピンを含む経口剤形 |
| JP2014141894A Expired - Fee Related JP6043758B2 (ja) | 2007-10-26 | 2014-07-10 | 酢酸リカルバゼピンを含む経口剤形 |
| JP2016147183A Pending JP2017014233A (ja) | 2007-10-26 | 2016-07-27 | 酢酸リカルバゼピンを含む経口剤形 |
| JP2018120334A Pending JP2018172407A (ja) | 2007-10-26 | 2018-06-26 | 酢酸リカルバゼピンを含む経口剤形 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014141894A Expired - Fee Related JP6043758B2 (ja) | 2007-10-26 | 2014-07-10 | 酢酸リカルバゼピンを含む経口剤形 |
| JP2016147183A Pending JP2017014233A (ja) | 2007-10-26 | 2016-07-27 | 酢酸リカルバゼピンを含む経口剤形 |
| JP2018120334A Pending JP2018172407A (ja) | 2007-10-26 | 2018-06-26 | 酢酸リカルバゼピンを含む経口剤形 |
Country Status (24)
| Country | Link |
|---|---|
| US (5) | US8372431B2 (enExample) |
| EP (2) | EP2214636B1 (enExample) |
| JP (4) | JP2011500797A (enExample) |
| KR (3) | KR20170004034A (enExample) |
| CN (1) | CN101848698A (enExample) |
| AR (1) | AR069031A1 (enExample) |
| AU (1) | AU2008317584B2 (enExample) |
| BR (1) | BRPI0818680B1 (enExample) |
| CA (1) | CA2703313C (enExample) |
| CY (1) | CY1118350T1 (enExample) |
| DK (1) | DK2214636T3 (enExample) |
| ES (2) | ES2898202T3 (enExample) |
| HR (1) | HRP20161329T1 (enExample) |
| HU (1) | HUE030788T2 (enExample) |
| IL (1) | IL205160A0 (enExample) |
| LT (1) | LT2214636T (enExample) |
| MX (1) | MX2010004323A (enExample) |
| PL (1) | PL2214636T3 (enExample) |
| PT (2) | PT2214636T (enExample) |
| RS (1) | RS55376B1 (enExample) |
| RU (1) | RU2546521C2 (enExample) |
| SI (1) | SI2214636T1 (enExample) |
| UA (1) | UA110012C2 (enExample) |
| WO (1) | WO2009054743A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| CN102573807A (zh) | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
| CA2769181C (en) | 2009-07-27 | 2017-11-28 | Bial-Portela & Ca., S.A. | Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia |
| EP3970702A1 (en) | 2009-10-26 | 2022-03-23 | Merck Sharp & Dohme Corp. | Solid pharmaceutical compositions containing an integrase inhibitor |
| US20120121703A1 (en) * | 2010-07-20 | 2012-05-17 | Japan Tobacco Inc. | Tablet containing ferric citrate |
| TR201008460A1 (tr) * | 2010-10-15 | 2012-05-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Eslikarbazepinin saşe formülasyonları. |
| MX350531B (es) | 2010-12-31 | 2017-09-08 | BIAL PORTELA & Cª S A | Granulados que comprenden acetato de eslicarbazepina. |
| RU2639120C2 (ru) | 2011-08-26 | 2017-12-19 | Биал-Портела Энд Ка, С.А. | Лечение с использованием ацетата эсликарбазепина или эсликарбазепина |
| EP3103444A1 (en) | 2015-06-09 | 2016-12-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical compositions of lacosamide and eslicarbazepine |
| PT3402488T (pt) * | 2015-12-18 | 2022-01-25 | Jubilant Generics Ltd | Formas de dosagem orais sólidas de eslicarbazepina |
| WO2018004391A1 (ru) * | 2016-06-29 | 2018-01-04 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция, содержащая комбинацию мемантина и мелатонина |
| CN106913550B (zh) * | 2017-03-10 | 2019-12-17 | 扬子江药业集团北京海燕药业有限公司 | 一种醋酸艾司利卡西平片的制备方法 |
| WO2019058354A1 (en) * | 2017-09-25 | 2019-03-28 | Jubilant Generics Limited | SUSPENSION OF ESLICARBAZÉPINE |
| US11318145B2 (en) | 2018-09-25 | 2022-05-03 | Jubilant Generics Limited | Eslicarbazepine suspension |
| EA037195B1 (ru) * | 2018-03-28 | 2021-02-18 | Акционерное Общество "Химфарм" | Биологически активная добавка для улучшения функционального состояния дыхательной системы и восстановления иммунной системы (варианты) |
| WO2020054647A1 (ja) | 2018-09-14 | 2020-03-19 | 学校法人慶應義塾 | アストロサイトの製造方法 |
| HUP1900153A1 (hu) | 2019-05-14 | 2020-11-30 | Meditop Gyogyszeripari Kft | Eszlikarbazepin-acetát tartalmú granulátum, ennek elõállítása, ezt tartalmazó egyéb gyógyszerkészítmények, és ezek alkalmazása |
| US20210346324A1 (en) * | 2020-05-05 | 2021-11-11 | NeuroBo Therapeutics, Inc. | Niclosamide Formulations and Methods of Use |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
| ZA953078B (en) | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
| PT101732B (pt) | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
| US6296873B1 (en) * | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
| CO4920215A1 (es) | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
| GB9721497D0 (en) | 1997-10-09 | 1997-12-10 | Ciba Geigy Ag | Organic compounds |
| NZ505123A (en) * | 1997-12-19 | 2003-07-25 | Smithkline Beecham Corp | Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof |
| SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| UA74141C2 (uk) | 1998-12-09 | 2005-11-15 | Дж.Д. Сірл Енд Ко. | Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти) |
| IN190699B (enExample) * | 2001-02-02 | 2003-08-16 | Sun Pharmaceutical Ind Ltd | |
| GB0111566D0 (en) | 2001-05-11 | 2001-07-04 | Portela & Ca Sa | Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide |
| GB0112812D0 (en) | 2001-05-25 | 2001-07-18 | Portela & Ca Sa | Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom |
| AU2003231919A1 (en) * | 2002-03-14 | 2003-09-22 | Sun Pharmaceutical Industries Limited | Oral controlled drug delivery system containing carbamazepine |
| WO2003101430A1 (de) | 2002-05-31 | 2003-12-11 | Desitin Arzneimittel Gmbh | Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung |
| DE10224170A1 (de) | 2002-05-31 | 2003-12-11 | Desitin Arzneimittel Gmbh | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung |
| DE10230027A1 (de) | 2002-07-04 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen auf der Basis von Natriumkanalblockern und Magnesiumsalzen |
| GB0221956D0 (en) | 2002-09-20 | 2002-10-30 | Novartis Ag | Organic compounds |
| CA2497780A1 (en) | 2002-10-17 | 2004-04-29 | Novartis Ag | Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors |
| US20040087642A1 (en) | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
| GB2401605A (en) | 2003-05-12 | 2004-11-17 | Portela & Ca Sa | Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof |
| EP1750717B1 (en) * | 2004-02-11 | 2017-07-19 | Rubicon Research Private Limited | Controlled release pharmaceutical compositions with improved bioavailability |
| KR101289564B1 (ko) | 2004-03-17 | 2013-07-24 | 란세스 엘라스토머즈 비.브이. | 아미딘 리간드를 포함하는 중합촉매 |
| PE20051156A1 (es) * | 2004-03-22 | 2006-02-13 | Novartis Ag | Formulaciones de matriz orales que comprenden licarbazepina |
| AR048672A1 (es) | 2004-03-22 | 2006-05-17 | Novartis Ag | Tabletas de desintegracion que comprenden licarbazepina |
| GB2416167A (en) | 2004-07-13 | 2006-01-18 | Portela & Ca Sa | Chiral inversion and esterification of (S)- and (R)-10-hydroxy-dibenzazepine carboxamides |
| EP1787642A1 (en) | 2004-11-10 | 2007-05-23 | Teva Pharmaceutical Industries Ltd. | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| GB0425320D0 (en) | 2004-11-17 | 2004-12-22 | Johnson Matthey Plc | Diamines |
| GB2422149A (en) | 2005-01-14 | 2006-07-19 | Portela & Ca Sa | Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide |
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| EP2386303A1 (en) | 2005-05-06 | 2011-11-16 | Bial-Portela & CA, S.A. | Eslicarbazepine acetate and methods of use |
| BRPI0520258A2 (pt) | 2005-05-06 | 2009-09-15 | Portela & Ca Sa | uso de uma composição farmacêutica, método para preparar uma composição farmacêutica, e, uso de uma quantidade eficaz de acetato de eslicarbazepina |
| US8059672B2 (en) | 2005-05-18 | 2011-11-15 | Sprint Communications Company L.P. | Internet communications between wireless base stations and service nodes |
| US20070071819A1 (en) * | 2005-05-30 | 2007-03-29 | Kesarwani Amit K | Multiple unit modified release compositions of carbamazepine and process for their preparation |
| WO2007008576A2 (en) | 2005-07-08 | 2007-01-18 | Taro Pharmaceuticals U.S.A., Inc. | Oxcarbazepine formulation |
| GB0515690D0 (en) | 2005-07-29 | 2005-09-07 | Portela & Ca Sa | Asymmetric catalytic reduction |
| WO2007029093A2 (en) | 2005-09-05 | 2007-03-15 | Ranbaxy Laboratories Limited | Pharmaceutical dosage forms of oxcarbazepine |
| CN101336105A (zh) | 2006-01-31 | 2008-12-31 | 特瓦制药工业有限公司 | 奥卡西平药物制剂及其制备方法，其中奥卡西平具有宽且多峰的粒度分布 |
| EP2029118A2 (en) | 2006-01-31 | 2009-03-04 | Teva Pharmaceutical Industries, Inc. | Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| GB0603008D0 (en) | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| GB2437078A (en) | 2006-04-11 | 2007-10-17 | Portela & Ca Sa | 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives |
| WO2008037044A1 (en) | 2006-09-27 | 2008-04-03 | Medley S.A. Indústria Farmacêutica | Oxcarbazepine-containing oral formulation and a process to obtain the same |
| US20080138403A1 (en) | 2006-12-08 | 2008-06-12 | Sun Pharmaceutical Industries Ltd. | Pharmaceutical dosage forms of oxcarbazepine |
| US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| PT3402488T (pt) | 2015-12-18 | 2022-01-25 | Jubilant Generics Ltd | Formas de dosagem orais sólidas de eslicarbazepina |
-
2008
- 2008-10-23 US US12/257,240 patent/US8372431B2/en active Active
- 2008-10-24 PT PT88423686T patent/PT2214636T/pt unknown
- 2008-10-24 KR KR1020167036806A patent/KR20170004034A/ko not_active Ceased
- 2008-10-24 MX MX2010004323A patent/MX2010004323A/es active IP Right Grant
- 2008-10-24 ES ES16180687T patent/ES2898202T3/es active Active
- 2008-10-24 PT PT161806872T patent/PT3202392T/pt unknown
- 2008-10-24 HU HUE08842368A patent/HUE030788T2/en unknown
- 2008-10-24 EP EP08842368.6A patent/EP2214636B1/en active Active
- 2008-10-24 AR ARP080104652A patent/AR069031A1/es unknown
- 2008-10-24 PL PL08842368T patent/PL2214636T3/pl unknown
- 2008-10-24 BR BRPI0818680-4A patent/BRPI0818680B1/pt not_active IP Right Cessation
- 2008-10-24 LT LTEP08842368.6T patent/LT2214636T/lt unknown
- 2008-10-24 SI SI200831687A patent/SI2214636T1/sl unknown
- 2008-10-24 ES ES08842368.6T patent/ES2607002T3/es active Active
- 2008-10-24 AU AU2008317584A patent/AU2008317584B2/en active Active
- 2008-10-24 DK DK08842368.6T patent/DK2214636T3/en active
- 2008-10-24 RU RU2010121135/15A patent/RU2546521C2/ru active
- 2008-10-24 JP JP2010530951A patent/JP2011500797A/ja active Pending
- 2008-10-24 CA CA2703313A patent/CA2703313C/en active Active
- 2008-10-24 HR HRP20161329TT patent/HRP20161329T1/hr unknown
- 2008-10-24 CN CN200880112983A patent/CN101848698A/zh active Pending
- 2008-10-24 UA UAA201006417A patent/UA110012C2/ru unknown
- 2008-10-24 KR KR1020187037643A patent/KR102116087B1/ko active Active
- 2008-10-24 RS RS20160895A patent/RS55376B1/sr unknown
- 2008-10-24 KR KR1020107011233A patent/KR20100093057A/ko not_active Ceased
- 2008-10-24 EP EP16180687.2A patent/EP3202392B1/en active Active
- 2008-10-24 WO PCT/PT2008/000043 patent/WO2009054743A1/en not_active Ceased
-
2010
- 2010-04-18 IL IL205160A patent/IL205160A0/en unknown
-
2013
- 2013-01-30 US US13/754,439 patent/US20130150348A1/en not_active Abandoned
- 2013-12-17 US US14/108,615 patent/US9566244B2/en active Active
-
2014
- 2014-07-10 JP JP2014141894A patent/JP6043758B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-27 JP JP2016147183A patent/JP2017014233A/ja active Pending
- 2016-12-14 CY CY20161101294T patent/CY1118350T1/el unknown
-
2017
- 2017-01-04 US US15/397,945 patent/US10912781B2/en active Active
-
2018
- 2018-06-26 JP JP2018120334A patent/JP2018172407A/ja active Pending
-
2021
- 2021-01-29 US US17/248,581 patent/US20210322436A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011500797A5 (enExample) | ||
| JP2014237658A5 (enExample) | ||
| RU2010121135A (ru) | Лекарственные формы для перорального применения, содержащие ацетат ликарбазепина | |
| JP2006527256A5 (enExample) | ||
| CN116490178A (zh) | Sglt-2抑制剂与血管紧张素受体阻滞剂的组合物及用途 | |
| ES2337848T3 (es) | Formulaciones de valsartan. | |
| JP2020128442A (ja) | 酢酸亜鉛水和物錠及びその製造方法 | |
| CN101659643A (zh) | 一种氢氯噻嗪的晶形及其用途 | |
| CA2915432A1 (en) | Disintegrant free composition of cinacalcet | |
| KR101171375B1 (ko) | 난용성 약물을 함유하는 경구 제형 | |
| RS58214B1 (sr) | Farmaceutski sastav koji sadrži kandesartan cileksetil i amlodipin | |
| JP6160263B2 (ja) | ロキソプロフェン含有医薬組成物 | |
| CN102164918B (zh) | 固体药物组合物 | |
| CN113384547A (zh) | 一种奥美拉唑铝碳酸镁复合片及其制备工艺 | |
| JP2006328000A (ja) | 経口投与用製剤 | |
| CN114945356A (zh) | 包括阿托伐他汀以及怡妥锭的片剂 | |
| JP6027710B1 (ja) | 糖尿病治療用固形製剤 | |
| KR20010072269A (ko) | 이부프로펜 및 돔페리돈을 포함하는 약제학적 조성물 | |
| CN103505460B (zh) | 一种制备氯沙坦钾氢氯噻嗪组合物的方法 | |
| JP2013216701A (ja) | 経口投与用製剤 | |
| JP4567640B2 (ja) | 小型化塩酸サルポグレラート経口投与製剤 | |
| WO2014006635A2 (en) | Solid oral compositions of silodosin | |
| JP4870402B2 (ja) | プランルカスト水和物含有錠の製造方法 | |
| JP7362302B2 (ja) | レベチラセタムを含有する錠剤とその製造方法 | |
| KR101451327B1 (ko) | 보센탄의 제어방출성 다층 정제 및 그 제조방법 |